Diagnostics

RSS

MRI contrast agents from Nycomed Salutar

Nov. 1, 1996

Cell motility factor with potential in cancer diagnostics and therapeutics available for licensing

Oct. 25, 1996

Licensees sought for antibodies specific for P31 antigen for use in lung cancer detection

Oct. 25, 1996

IRS-2 polypeptide for diagnosis of insulin- or immune-related disorders available for licensing

Oct. 25, 1996

European approval recommended for LeukoScan

Oct. 25, 1996

FDA accepts EchoGen filing

Oct. 25, 1996

Techtide P829 in phase III for detecting the spread of melanoma

Oct. 25, 1996

Nymox prepares filings for Alzheimer's diagnostic test

Oct. 25, 1996

Genzyme launches HDL cholesterol test in the U.S.

Oct. 25, 1996

Diagnostic Products expands its array of allergy tests

Oct. 25, 1996